Gastro Medical News about colorectal

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases
Surgery, 06/25/09

Neumann UP et al. – Study reports that liver resection offers a long-term survival benefit for patients with colorectal liver metastases (CRM), even when tumor growth proceeds during pre-operative chemotherapy.

Methods

Aim was to identify risk factors for poor outcome in pts with pre-operative chemotherapy of CRM
160 pts analyzed; 3 groups of patients were identified:
- 44 pts (27.5%) had a tumor response
- 20 (12.5%) showed stable disease, and
- 96 (60%) pts had tumor progression while on chemotherapy
Median f/u was 2.4 yrs; all available clinicopathologic variables possibly associated with outcome were evaluated

Results

Survival was 88%, 53%, and 37% at 1, 3, and 5 yrs
Factors associated with poor outcome:
- Noncurative resection
- Carcinoembryonic antigen levels >200 ng/ml
- Tumor grading
- Size of the largest tumor >5 cm, and
- Number of metastases
Multivariate analysis: tumor free margin and tumor grading correlated with the outcome
Tumor progression while on chemotherapy had no influence on the long-term survival

<< Previous
One-stage ultrasonographically guided hepatectomy for multiple...

Next >>
Meal Support Therapy Reduces the Use of Nasogastric Feeding for...